Hospital pharmacies should develop safe handling policies to protect healthcare workers (HCWs) who are exposed to cell and gene therapies (CGTs). Such efforts are critical because these novel agents are not yet included in hazardous drug lists from the National Institute for Occupational Safety and Health (NIOSH), experts noted at the ASHP 2023 Midyear Clinical Meeting & Exhibition, in Anaheim, Calif.
For example, because some CGTs can be prepared in the same biological safety